Evidence map›Paper›PMID 37566492›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2023

End-Stage Idiopathic Pulmonary Fibrosis Lung Microenvironment Promotes Impaired NK Activity.

Tamara Cruz, Paula A Agudelo Garcia, Julián A Chamucero-Millares, Anna Bondonese, Nilay Mitash, John Sembrat, Tracy Tabib, Wenping Zhang, Nouraie Seyed, Victor Peters and 5 more

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. The transcriptome of CD14The European respiratory journal · 2026
    Article
  3. Review
  4. Article
  5. Immunological mechanisms and therapeutic approaches in pulmonary fibrosis.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  6. Article
  7. Mechanisms and markers of lung ageing in health and disease.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  8. Article
  9. Immunobiology of pulmonary fibrosis.Frontiers in immunology · 2025
    Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Tamara CruzFundacio Clinic per a la Recerca Biomedica, IDIBAPS, 08036 Barcelona, Spain.ORCID 0000-0002-6362-6348
Paula A Agudelo GarciaDivision of Pulmonary, Critical Care & Sleep Medicine, The Ohio State University, Columbus, OH.ORCID 0000-0002-6764-6450
Julián A Chamucero-MillaresDivision of Pulmonary, Critical Care & Sleep Medicine, The Ohio State University, Columbus, OH.
Anna BondoneseDivision of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.ORCID 0000-0001-9489-6052
Nilay MitashDivision of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.ORCID 0000-0001-8899-0915
John SembratDivision of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.ORCID 0000-0003-4108-803X
Tracy TabibDivision of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Wenping ZhangDivision of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Nouraie SeyedDivision of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Victor PetersDivision of Pulmonary, Critical Care & Sleep Medicine, The Ohio State University, Columbus, OH.ORCID 0009-0005-9723-4704
Sean StaceyDivision of Pulmonary, Critical Care & Sleep Medicine, The Ohio State University, Columbus, OH.ORCID 0009-0005-7549-0328
Dario VignaliDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.ORCID 0000-0002-2771-5992
Ana L MoraDivision of Pulmonary, Critical Care & Sleep Medicine, The Ohio State University, Columbus, OH.ORCID 0000-0003-1653-8318
Robert LafyatisDivision of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Mauricio RojasDivision of Pulmonary, Critical Care & Sleep Medicine, The Ohio State University, Columbus, OH.ORCID 0000-0001-7340-4784
University of Pittsburgh · USThe Ohio State University · USFundació Clínic per a la Recerca Biomèdica · ESThe Ohio State University Wexner Medical Center · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
WILD TYPE P53-BASED ADJUVANT IMMUNOTHERAPY FOR SCCHNP50CA097190 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Greg M. Delgoffe · 2004 to 2026
$49.6M
Systems Biology CoreP50AR080612 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROBERT A. LAFYATIS · 2022 to 2026
$9.5M
Mapping Age-Related Changes in the LungU01HL145550 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BENOS, PANAGIOTIS V, FINKEL, TOREN · 2019 to 2022
$2.4M
Aging of Mesenchymal Stem Cells Missing Link in IPFR01HL123766 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROJAS, MAURICIO · 2015 to 2018
$1.9M
Metabolic Regulation of the Epigenetic Landscape in T cell ExhaustionF32CA261023 · NCI · UNIVERSITY OF PENNSYLVANIA · PI AGUDELO GARCIA, PAULA ANDREA · 2021 to 2023
$216k
NCI NIH HHS F32 CA261023NCI NIH HHS P30 CA047904NCI NIH HHS P50 CA097190NHLBI NIH HHS R01 HL123766NHLBI NIH HHS U01 HL145550NIAMS NIH HHS P50 AR080612
6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fibrotic age-related chronic lung disease characterized by the accumulation of senescent cells. Whether impaired immune response is responsible for the accumulation of senescent cells in the IPF lung remains unknown. In this study, we characterized the NK phenotype in IPF lungs via flow cytometry using 5-dodecanoylaminofluorescein di-β-d-galactopyranoside, markers of tissue residence, and chemokine receptors. The effect of the lung microenvironment was evaluated using lung fibroblast (LF) conditioned media (CM), and the bleomycin-induced pulmonary fibrosis mouse model was used to assess the in vivo relationship between NK cells and the accumulation of senescent cells. We found that NK cells from the lower lobe of IPF patients exhibited immune-senescent and impaired CD57-NKG2A+ phenotype. We also observed that culture of NK cells from healthy donors in CM from IPF lower lobe lung fibroblasts induced a senescent-like phenotype and impaired cytotoxic capacity. There is an impaired NK recruitment by LF, and NKs presented decreased migration toward their CM. In addition, NK cell-depleted mice treated with bleomycin showed increased collagen deposition and accumulation of different populations of senescent cells compared with controls. The IPF lung microenvironment induces a dysfunctional NK phenotype limiting the clearance of lung senescent cells and the resolution of lung fibrosis. We propose that impaired NK activity could be one of the mechanisms responsible for perpetuating the accumulation of senescent cells in IPF lungs.

Indexed as

Antineoplastic AgentsIdiopathic Pulmonary FibrosisAnimalsBleomycinFibroblastsFibrosisLungMiceAntineoplastic AgentsBleomycin

Identifiers

PMID37566492
PMCPMC12225614
OpenAlexW4385759137

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.